Literature DB >> 3386387

Adenocarcinomas of major and minor salivary gland origin: a histopathologic review of treatment failure patterns.

H M Matsuba1, M Mauney, J R Simpson, S E Thawley, F J Pikul.   

Abstract

Fifty-four cases of adenocarcinoma of major and minor salivary gland origin were seen between 1960 and 1980. Fifty of these were treated definitively. Planned surgery combined with radiation was the initial treatment for 22 patients (44%), surgery alone for 15 (30%), and radiation alone for 13 (26%). Of the patients receiving surgery with curative intent, 82% underwent complete resections (i.e., negative margins). Cervical lymph node involvement was present in 23% of cases, and 73% of these patients died of their disease within 3 years. Distant metastases developed in 37% of patients, with a median time of 1 year; 93% of these patients died within 3 years. Histologic grading was performed using objective criteria. Thirty-four percent of tumors were well-differentiated, 27% moderately differentiated, and 39% poorly differentiated. Patients with well-differentiated adenocarcinomas tended to survive disease-free longer and developed fewer distant metastases than those patients with moderately or poorly differentiated tumors.

Entities:  

Mesh:

Year:  1988        PMID: 3386387     DOI: 10.1288/00005537-198807000-00021

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Primary esophageal adenoid cystic carcinoma.

Authors:  Youn Ju Na; Ki-Nam Shim; Min-Jung Kang; Ji Min Jung; Chang Yun Ha; Hae Sun Jung; Su Jung Baik; Seong-Eun Kim; Sung-Ae Jung; Kwon Yoo; Il Hwan Moon; Min Sun Cho
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

2.  Adenocarcinoma of the sublingual salivary gland - A case report.

Authors:  Sahana Adirajaiah; Venkatesh Anehosur; K Gopalakrishnan
Journal:  J Oral Biol Craniofac Res       Date:  2012-10-17

3.  The buccal minor salivary glands as starting point for a metastasizing adenocarcinoma--report of a case.

Authors:  Tobias Ettl; Johannes Kleinheinz; Ravi Mehrotra; Stephan Schwarz; Torsten Eugen Reichert; Oliver Driemel
Journal:  Head Face Med       Date:  2008-07-30       Impact factor: 2.151

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.